Cost to government and society of chronic kidney disease stage 1-5: A national cohort study

Internal Medicine Journal

Volumn 45, Issue 7, 2015, Pages 741-747

  Wyld, M L R ^a,b   Lee, C M Y ^c   Zhuo, X ^d   White, S ^a,b   Shaw, J E ^e   Morton, R L ^a,f   Colagiuri, S ^c   Chadban, S J ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Australia; Chronic kidney disease; Expenditure; Health economics

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; COST OF ILLNESS; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; CHRONIC KIDNEY FAILURE; CLASSIFICATION; ECONOMICS; MIDDLE AGED; PATHOLOGY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; AUSTRALIA; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HEALTH CARE COSTS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC;

EID: 84933567047     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12797     Document Type: Article

References (23)

1. Australian Institute of Health and Welfare. An overview of chronic kidney disease in Australia 2009, Cat. no. PHE 111. Canberra: AIHW. 2009.
2. Australian Institute of Health and Welfare. Health care expenditure on chronic kidney disease in Australia. Cat. no. PHE 117. Canberra: AIHW; 2009.
3. Grace B, Hurst K, McDonald S. Stock and Flow: Australia and New Zealand Dialysis and Transplant Registry Report 2012. Adelaide: Australia and New Zealand Dialysis and Transplant Registry; 2012.
4. Hunsiker L. The consequences and costs of chronic kidney disease before ESRD. J Am Soc Nephrol 2004; 15: 1363-1364.
5. Lee C, Colagiuri R, Magliano D, Cameron A, Shaw J, Zimmet P etal. The cost of diabetes in adults in Australia. Diabetes Res Clin Pract 2013; 99: 385-390.
6. Mogyorosy Z, Smith P. The Main Methodological Issues in Costing Health Care Services: A Literature Review. York, UK: Centre for Health Economics, University of York; 2005.
7. Barr E, Magliano D, Zimmet P, Polkinghorne K, Atkins R, Dunstan D etal. AusDiab 2005: The Australian Diabetes, Obesity and Lifestyle Study. Tracking the Accelerating Epidemic: Its Causes and Outcomes. Melbourne: International Diabetes Institute; 2006.
8. Dunstan D, Zimmet P, Welborn T, Cameron A, Shaw J, de Courten M etal. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab): methods and response rates. Diabetes Res Clin Pract 2002; 57: 119-129.
9. Levey A, Eckardt K, Tsukamoto Y, Levin A, Coresh J, Rossert J etal. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100.
10. 2. Am J Kidney Dis 2010; 56: 486-495.
11. Magliano D, Barr E, Zimmet P, Cameron A, Dunstan D, Colagiuri S etal. Glucose indices, health behaviours and the incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Diabetes Care 2008; 31: 267-272.
12. Colagiuri S, Lee C, Colagiuri R, Magliano D, Shaw J, Zimmet P etal. The cost of overweight and obesity in Australia. Med J Aust 2010; 2010: 260-264.
13. Honeycutt A, Segel J, Zhuo X, Hoerger T, Imai K, Williams D. Medical costs of CKD in the Medicare population. J Am Soc Nephrol 2013; 24: 1478-1483.
14. Glick H, Doshi J, Sonnad S, Polsky D. Economic Evaluation in Clinical Trials. Oxford, UK: Oxford University Press; 2007; 109.
15. International Monetary Fund. World Economic Outlook Database. October 2012. [cited 2014 May 28]. Available from URL: http://www.imf.org/external/pubs/ft/weo/2012/02/weodata/index.aspx
16. Shemilt I, Thomas J, Morciano M. A web-based tool for adjusting costs to a specific target currency and price year. Evid Policy 2010; 6: 51-59.
17. Australian Bureau of Statistics. Population by Age and Sex, Australian States and Territories, June 2012. 2012. [cited 2014 May 28]. Available from URL: http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3101.0Jun2012?OpenDocument
18. Chadban S, Briganti E, Kerr P, Dunstan D, Welborn T, Zimmet P etal. Prevalence of kidney damage in Australian adults: the AusDiab Kidney Study. J Am Soc Nephrol 2003; 14(Suppl 2): S131-138.
19. Smith D, Gullion C, Nichols G, Keith D, Brown J. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 2004; 15: 1300-1306.
20. Howard K, White S, Salkeld G, McDonald S, Craig J, Chadban S etal. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis. Value Health 2010; 13: 196-208.
21. Arguedas J, Perez M, Wright J. Treatment blood pressure targets for hypertension. Cochrane Database Syst Rev 2009; CD004349.
22. Boulware L, Jaar B, Tarver-Carr M, Brancati F, Powe N. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA 2003; 290: 3101-3114.
23. Mathew T, Corso O, Ludlow M, Boyle A, Cass A, Chadban S etal. Screening for chronic kidney disease in Australia: a pilot study in the community and workplace. Kidney Int 2010; 116: S9-16.